Type to search

Pfizer and BioNTech Complete Submission to European Medicines Agency for Omicron BA.4/BA.5 Adapted Bivalent | Pharmtech Focus
Pfizer and BioNTech Advance COVID-19 Vaccine Strategy With Study Start of Next-Generation Vaccine Candidate Based on Enhanced Spike Protein Design | Pharmtech Focus
BioNTech Starts Construction of First mRNA Vaccine Manufacturing Facility in Africa | Pharmtech Focus